Close Menu

executive appointment

The company attributed its revenue shortfall to billing issues in the prenatal testing business and announced that CFO Bryan Riggsbee will be interim CEO.

eric dishman

"I'm on this planet thanks to being an early prototype of precision medicine myself," said Eric Dishman, who the NIH has picked to lead the PMI Cohort Program.

The firm said the two executives failed to present a lucrative corporate opportunity to Trovagene and took it for their own personal benefit instead.

The new appointments, which have been unanimously approved by the company's board, will become effective on July 5.

NEW YORK (GenomeWeb) – NantHealth announced on Wednesday that it has received a $250 million investment from the Kuwait Investment Authority and has named new members to its management team.

NEW YORK (GenomeWeb) – Agilent Technologies said after the close of the market Wednesday that its board of directors has approved the separation of Keysight Technologies, the new name for its electronic measurement subsidiary, from the firm and has named a successor to current CEO Bill Sullivan.

NEW YORK (GenomeWeb) – Epic Sciences has raised $30 million in a Series C round of private financing that it will use to support development of its circulating tumor cell analysis platform.

NEW YORK (GenomeWeb News) – Biotech firm Biodesy said today that it has closed a $15 million Series A financing round with investments from 5AM Ventures, Pfizer Venture Investments, and Roche Venture Fund.

NEW YORK (GenomeWeb News) – Illumina today announced sweeping changes to its organization in order to maintain growth in its existing markets and to move into new ones.

NEW YORK (GenomeWeb News) – Personalis has formed a UK subsidiary, Personalis UK Limited, to serve its customers in Europe.
Menlo Park, Calif.-based Personalis provides researchers and clinicians human DNA sequencing and interpretation services.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.